InMed Pharmaceuticals (INM) Cash & Current Investments (2021 - 2025)
Historic Cash & Current Investments for InMed Pharmaceuticals (INM) over the last 5 years, with Q4 2025 value amounting to $7.0 million.
- InMed Pharmaceuticals' Cash & Current Investments rose 2522.92% to $7.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $7.0 million, marking a year-over-year increase of 2522.92%. This contributed to the annual value of $11.1 million for FY2025, which is 6809.98% up from last year.
- As of Q4 2025, InMed Pharmaceuticals' Cash & Current Investments stood at $7.0 million, which was up 2522.92% from $9.4 million recorded in Q3 2025.
- In the past 5 years, InMed Pharmaceuticals' Cash & Current Investments ranged from a high of $15.4 million in Q3 2021 and a low of $4.7 million during Q1 2025
- In the last 5 years, InMed Pharmaceuticals' Cash & Current Investments had a median value of $8.3 million in 2023 and averaged $8.5 million.
- In the last 5 years, InMed Pharmaceuticals' Cash & Current Investments crashed by 4129.24% in 2024 and then skyrocketed by 6809.98% in 2025.
- Quarter analysis of 5 years shows InMed Pharmaceuticals' Cash & Current Investments stood at $11.3 million in 2021, then increased by 1.5% to $11.5 million in 2022, then decreased by 16.67% to $9.6 million in 2023, then crashed by 41.29% to $5.6 million in 2024, then rose by 25.23% to $7.0 million in 2025.
- Its Cash & Current Investments was $7.0 million in Q4 2025, compared to $9.4 million in Q3 2025 and $11.1 million in Q2 2025.